Corrigendum to "BML-111, the lipoxin A4 agonist, modulates VEGF or CoCl2-induced migration, angiogenesis and permeability in tumor-derived endothelial cells"[Immunology Letters 230 (2021) 27-35]

Affiliations

• ¹ Department of Pathology, Second Affiliated Hospital of Nanchang University, 330006, Nanchang, Jiangxi China.
• ² Department of General Medicine, Second Affiliated Hospital of Nanchang University, 330006, Nanchang, Jiangxi China.
• ³ Department of Breast Surgery, Second Affiliated Hospital of Nanchang University, 330006, Nanchang, Jiangxi China.
• ⁴ Department of Pathology, Second Affiliated Hospital of Nanchang University, 330006, Nanchang, Jiangxi China. Electronic address: haohua410@126.com.